Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CRIP2 Antibody (5S293)

(Synonyms: ESP1, cysteine-rich protein 2, CRP2, CRIP) Copy Product Info
🥰Excellent

Synonyms: ESP1, cysteine-rich protein 2, CRP2, CRIP

Catalog No. TMAY-02739 Copy Product Info
🥰Excellent
Anti-CRIP2 Antibody (5S293) is a Mouse antibody targeting CRIP2. Anti-CRIP2 Antibody (5S293) can be used in IHC-P.
Anti-CRIP2 Antibody (5S293)
Pack SizePriceUSA StockGlobal StockQuantity
100 μL$1997-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-CRIP2 Antibody (5S293) is a Mouse antibody targeting CRIP2. Anti-CRIP2 Antibody (5S293) can be used in IHC-P.
SynonymsESP1, cysteine-rich protein 2, CRP2, CRIP
Ig Type
Mouse IgG1
Clone
5S293
Reactivity
Human
Specificity
Human CRIP2
Application
Recommended Dose
IHC-P: 1:50-1:200
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CRIP2 (rh CRIP2; TMPY-03342; P52943; Met1-Pro208). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundCRIP2 is a putative transcription factor. It has a widespread tissue expression and is highly expressed in heart. CRIP2 contains two LIM zinc-binding domains. CRIP2 may participate in the differentiation of smooth muscle tissue. It also plays an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis. CRIP2 acts as a transcription repressor of the NF-κB-mediated proangiogenic cytokine expression and thus functionally inhibits tumor formation and angiogenesis. It interacts with the NF-κB/p65 to inhibit its DNA-binding ability to the promoter regions of the major proangiogenesis cytokines critical for tumor progression, including IL6, IL8, and VEGF. In conclusion, we provide compelling evidence that CRIP2 acts as a transcription repressor of the NF-κB-mediated proangiogenic cytokine expression and thus functionally inhibits tumor formation and angiogenesis.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Human CRIP2 protein (TMPY-03342)
Antigen Species
Human
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: Anti-CRIP2 Antibody (5S293) chemical structure